Long-term benefit of atezolizumab plus chemotherapy in extensive stage small cell lung cancer (ES-SCLC): Exploratory analysis from the IMfirst study
Por:
García-Campelo, MR, Dómine, M, Carpeño, JDC, Vega, ALM, Aix, SP, Arriola, E, Carcereny, E, Majem, M, Vence, GH, Gonzalez, EE, Pradera, JF, Granados, ALOO, Morales, MG, Sureda, BM, Barragan, PL, Calderon, RA, Fajardo, CA, Crama, L, Laborda, NL and Dols, MC
Publicada:
1 oct 2023
Ahead of Print:
1 oct 2023
Resumen:
|